メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

大腸がん治療薬のパイプライン分析

Colorectal Cancer Drug Development Pipeline Review, 2017

発行 GBI Research 商品コード 564938
出版日 ページ情報 英文 299 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.61円で換算しております。
Back to Top
大腸がん治療薬のパイプライン分析 Colorectal Cancer Drug Development Pipeline Review, 2017
出版日: 2017年09月22日 ページ情報: 英文 299 Pages
概要

当レポートでは、各種の大腸がん (直腸結腸がん) の治療薬の治験・開発動向について分析し、疾患の概要や、現在までの治療薬の開発・上市状況、現在治験中/審査中の主要なパイプライン製品の一覧、休止中・中止済みプロジェクトの概略、今後の治験の方向性や実現見通しなどについて調査しております。

第1章 目次

第2章 イントロダクション

  • 分析範囲
  • 肛門がん:概要
  • 直腸がん:概要
  • 大腸がん:概要

第3章 治療薬の開発

  • 肛門がん
  • 直腸がん
  • 大腸がん

第4章 治療薬の評価

  • 肛門がん
  • 直腸がん
  • 大腸がん

第5章 治療薬の開発に参加している企業

  • 肛門がん
  • 直腸がん
  • 大腸がん

第6章 現在休止中のプロジェクト

  • 肛門がん
  • 直腸がん
  • 大腸がん

第7章 開発が中止されたプロジェクト

  • 肛門がん
  • 大腸がん

第8章 製品開発のマイルストーン

  • 肛門がん
  • 直腸がん
  • 大腸がん

第9章 付録

図表一覧

目次
Product Code: GBIHC019IDB

Executive Summary:

Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness in the anal area. Predisposing factors include HPV infections, smoking and lowered immunity. There are a total of 17 products in development for this indication, by 16 companies. The key company operating in this pipeline space is Advaxis, with two pipeline products in development.

Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The common signs and symptoms of rectal cancer include a change in bowel habits, diarrhea, constipation, or feeling that the bowel does not empty completely, blood, either bright red or very dark in the stool, stools that are narrower than usual, general abdominal discomfort such as frequent gas pains, bloating, fullness or cramps, weight loss with no known reason, constant tiredness and vomiting. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a diet mostly from animal sources and personal or family history of polyps or colorectal cancer. There are a total of 10 products in development for this indication, developed by 10 companies. Key companies operating in this pipeline space include Abbvie and Advaxis.

Finally, colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason. Risk factors include smoking, heavy alcohol use, inflammatory bowel disease (IBD) and family history. There are a total of 581 products in development for this indication, by 334 companies and 56 academic institutions. Key companies operating in this pipeline space include Novartis, Roche and Abbvie.

Across all three indications, viral proteins, immune checkpoint proteins, kinases and DNA-related proteins are the most common targets, reflecting heavily both the pathophysiology and current treatment landscape associated with these diseases.

The report, "Colorectal Cancer Drug Development Pipeline Review, 2017" provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.

Scope:

  • Which companies are the most active within the pipeline for colorectal cancer therapeutics?
  • Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened in the field of colorectal cancer?

Reasons to buy:

  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Colorectal Cancer Report Coverage
  • 2.2. Anal Cancer. Overview
  • 2.3. Rectal Cancer. Overview
  • 2.4. Colorectal Cancer. Overview

3. Therapeutics Development

  • 3.1. Anal Cancer
  • 3.2. Rectal Cancer
  • 3.3. Colorectal Cancer

4. Therapeutics Assessment

  • 4.1. Anal Cancer
  • 4.2. Rectal Cancer
  • 4.3. Colorectal Cancer

5. Companies Involved in Therapeutics Development

  • 5.1. Anal Cancer
  • 5.2. Rectal Cancer
  • 5.3. Colorectal Cancer

6. Dormant Projects

  • 6.1. Anal Cancer
  • 6.2. Rectal Cancer
  • 6.3. Colorectal Cancer

7. Discontinued Products

  • 7.1. Anal Cancer
  • 7.2. Colorectal Cancer

8. Product Development Milestones

  • 8.1. Anal Cancer
  • 8.2. Rectal Cancer
  • 8.3. Colorectal Cancer

9. Appendix

  • 9.1. Methodology
  • 9.2. Coverage
  • 9.3. Secondary Research
  • 9.4. Primary Research
  • 9.5. Expert Panel Validation
  • 9.6. Contact Us
  • 9.7. Disclaimer

List of Tables

  • Table 1: Number of Products under Development for Anal Cancer
  • Table 2: Number of Products under Development by Companies Anal Cancer
  • Table 3: Products under Development by Companies Anal Cancer
  • Table 4: Number of Products under Development for Rectal Cancer
  • Table 5: Number of Products under Development by Companies Rectal Cancer
  • Table 6: Products under Development by Companies Rectal Cancer
  • Table 7: Number of Products under Development by Companies Colorectal Cancer
  • Table 8: Number of Products under Development by Universities/Institutes Colorectal Cancer
  • Table 9: Products under Development by Companies Colorectal Cancer
  • Table 10: Products under Development by Universities/Institutes Colorectal Cancer
  • Table 11: Number of Products by Stage and Target Anal Cancer
  • Table 12: Number of Products by Stage and Mechanism of Action Anal Cancer
  • Table 13: Number of Products by Stage and Route of Administration Anal Cancer
  • Table 14: Number of Products by Stage and Molecule Type Anal Cancer
  • Table 15: Number of Products by Stage and Target Rectal Cancer
  • Table 16: Number of Products by Stage and Mechanism of Action Rectal Cancer
  • Table 17: Number of Products by Stage and Route of Administration Rectal Cancer
  • Table 18: Number of Products by Stage and Molecule Type Rectal Cancer
  • Table 19: Number of Products by Stage and Target Colorectal Cancer
  • Table 20: Number of Products by Stage and Mechanism of Action Colorectal Cancer
  • Table 21: Number of Products by Stage and Route of Administration Colorectal Cancer
  • Table 22: Number of Products by Stage and Molecule Type Colorectal Cancer
  • Table 23: Anal Cancer - Pipeline by Advaxis Inc
  • Table 24: Anal Cancer - Pipeline by Amgen Inc
  • Table 25: Anal Cancer - Pipeline by Atara Biotherapeutics Inc
  • Table 26: Anal Cancer - Pipeline by Bayer AG
  • Table 27: Anal Cancer - Pipeline by BeiGene Ltd
  • Table 28: Anal Cancer - Pipeline by Eli Lilly and Company
  • Table 29: Anal Cancer - Pipeline by Immunovaccine Inc
  • Table 30: Anal Cancer - Pipeline by ISA Pharmaceuticals BV
  • Table 31: Anal Cancer - Pipeline by Merck & Co Inc
  • Table 32: Anal Cancer - Pipeline by Ono Pharmaceutical Co Ltd
  • Table 33: Anal Cancer - Pipeline by Oryx GmbH & Co KG
  • Table 34: Anal Cancer - Pipeline by PDS Biotechnology Corp
  • Table 35: Anal Cancer - Pipeline by Sun Pharma Advanced Research Company Ltd
  • Table 36: Anal Cancer - Pipeline by Taiwan Liposome Company Ltd
  • Table 37: Rectal Cancer - Pipeline by AbbVie Inc
  • Table 38: Rectal Cancer - Pipeline by Advaxis Inc
  • Table 39: Rectal Cancer - Pipeline by Eisai Co Ltd
  • Table 40: Rectal Cancer - Pipeline by GlaxoSmithKline Plc
  • Table 41: Rectal Cancer - Pipeline by Karyopharm Therapeutics Inc
  • Table 42: Rectal Cancer - Pipeline by Madrigal Pharmaceuticals Inc.
  • Table 43: Rectal Cancer - Pipeline by NewLink Genetics Corp
  • Table 44: Rectal Cancer - Pipeline by Peregrine Pharmaceuticals Inc
  • Table 45: Rectal Cancer - Pipeline by Regeneron Pharmaceuticals Inc
  • Table 46: Rectal Cancer - Pipeline by Taiwan Liposome Company Ltd
  • Table 47: Colorectal Cancer - Pipeline by 2cureX ApS
  • Table 48: Colorectal Cancer - Pipeline by 3-V Biosciences Inc
  • Table 49: Colorectal Cancer - Pipeline by 3SBio Inc
  • Table 50: Colorectal Cancer - Pipeline by 4SC AG
  • Table 51: Colorectal Cancer - Pipeline by AB Science SA
  • Table 52: Colorectal Cancer - Pipeline by AbbVie Inc
  • Table 53: Colorectal Cancer - Pipeline by AbGenomics International Inc
  • Table 54: Colorectal Cancer - Pipeline by Aclaris Therapeutics Inc
  • Table 55: Colorectal Cancer - Pipeline by Adamed Sp z oo
  • Table 56: Colorectal Cancer - Pipeline by Aduro BioTech Inc
  • Table 57: Colorectal Cancer - Pipeline by Advenchen Laboratories LLC
  • Table 58: Colorectal Cancer - Pipeline by Allinky Biopharma
  • Table 59: Colorectal Cancer - Pipeline by amcure GmbH
  • Table 60: Colorectal Cancer - Pipeline by Amgen Inc
  • Table 61: Colorectal Cancer - Pipeline by Antibe Therapeutics Inc
  • Table 62: Colorectal Cancer - Pipeline by APEIRON Biologics AG
  • Table 63: Colorectal Cancer - Pipeline by Apexigen Inc
  • Table 64: Colorectal Cancer - Pipeline by Aphios Corp
  • Table 65: Colorectal Cancer - Pipeline by Aposense Ltd
  • Table 66: Colorectal Cancer - Pipeline by ARMO Biosciences Inc
  • Table 67: Colorectal Cancer - Pipeline by ArQule Inc
  • Table 68: Colorectal Cancer - Pipeline by Array BioPharma Inc
  • Table 69: Colorectal Cancer - Pipeline by Asana BioSciences LLC
  • Table 70: Colorectal Cancer - Pipeline by Aslan Pharmaceuticals Pte Ltd
  • Table 71: Colorectal Cancer - Pipeline by Astellas Pharma Inc
  • Table 72: Colorectal Cancer - Pipeline by Astex Pharmaceuticals Inc
  • Table 73: Colorectal Cancer - Pipeline by AstraZeneca Plc
  • Table 74: Colorectal Cancer - Pipeline by Aurobindo Pharma Ltd
  • Table 75: Colorectal Cancer - Pipeline by AVEO Pharmaceuticals Inc
  • Table 76: Colorectal Cancer - Pipeline by B Cell Design SAS
  • Table 77: Colorectal Cancer - Pipeline by Basilea Pharmaceutica Ltd
  • Table 78: Colorectal Cancer - Pipeline by Bavarian Nordic A/S
  • Table 79: Colorectal Cancer - Pipeline by Bayer AG
  • Table 80: Colorectal Cancer - Pipeline by BeiGene Ltd
  • Table 81: Colorectal Cancer - Pipeline by Beijing Hanmi Pharmaceutical Co Ltd
  • Table 82: Colorectal Cancer - Pipeline by BeyondSpring Pharmaceuticals Inc
  • Table 83: Colorectal Cancer - Pipeline by Biocon Ltd
  • Table 84: Colorectal Cancer - Pipeline by Bionomics Ltd
  • Table 85: Colorectal Cancer - Pipeline by Bionovis SA
  • Table 86: Colorectal Cancer - Pipeline by Biotecnol Ltd
  • Table 87: Colorectal Cancer - Pipeline by Biothera Pharmaceutical Inc
  • Table 88: Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH
  • Table 89: Colorectal Cancer - Pipeline by Boston Biomedical Inc
  • Table 90: Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company
  • Table 91: Colorectal Cancer - Pipeline by Calithera Biosciences Inc
  • Table 92: Colorectal Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc
  • Table 93: Colorectal Cancer - Pipeline by Cantargia AB
  • Table 94: Colorectal Cancer - Pipeline by Carna Biosciences Inc
  • Table 95: Colorectal Cancer - Pipeline by Cascadian Therapeutics Inc
  • Table 96: Colorectal Cancer - Pipeline by CBT Pharmaceuticals Inc
  • Table 97: Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH
  • Table 98: Colorectal Cancer - Pipeline by Celgene Corp
  • Table 99: Colorectal Cancer - Pipeline by Celldex Therapeutics Inc
  • Table 100: Colorectal Cancer - Pipeline by Cellectar Biosciences Inc
  • Table 101: Colorectal Cancer - Pipeline by Celleron Therapeutics Ltd
  • Table 102: Colorectal Cancer - Pipeline by Celltrion Inc
  • Table 103: Colorectal Cancer - Pipeline by Celyad SA
  • Table 104: Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd
  • Table 105: Colorectal Cancer - Pipeline by ChoDang Pharm Co Ltd
  • Table 106: Colorectal Cancer - Pipeline by Chong Kun Dang Pharmaceutical Corp
  • Table 107: Colorectal Cancer - Pipeline by Cleave Biosciences Inc
  • Table 108: Colorectal Cancer - Pipeline by Cleveland BioLabs Inc
  • Table 109: Colorectal Cancer - Pipeline by COARE Biotechnology Inc
  • Table 110: Colorectal Cancer - Pipeline by Coherus BioSciences Inc
  • Table 111: Colorectal Cancer - Pipeline by Compugen Ltd
  • Table 112: Colorectal Cancer - Pipeline by Conatus Pharmaceuticals Inc
  • Table 113: Colorectal Cancer - Pipeline by Corvus Pharmaceuticals Inc
  • Table 114: Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc
  • Table 115: Colorectal Cancer - Pipeline by CrystalGenomics Inc
  • Table 116: Colorectal Cancer - Pipeline by Daiichi Sankyo Company Ltd
  • Table 117: Colorectal Cancer - Pipeline by DanDrit Biotech A/S
  • Table 118: Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals LLC
  • Table 119: Colorectal Cancer - Pipeline by Dr. Reddy's Laboratories Ltd
  • Table 120: Colorectal Cancer - Pipeline by eFFECTOR Therapeutics Inc
  • Table 121: Colorectal Cancer - Pipeline by Eisai Co Ltd
  • Table 122: Colorectal Cancer - Pipeline by Eli Lilly and Co
  • Table 123: Colorectal Cancer - Pipeline by Endor Nanotechnologies SL
  • Table 124: Colorectal Cancer - Pipeline by Ensol Biosciences Inc
  • Table 125: Colorectal Cancer - Pipeline by EntreChem SL
  • Table 126: Colorectal Cancer - Pipeline by Enzene Biosciences Ltd
  • Table 127: Colorectal Cancer - Pipeline by Enzo Biochem Inc
  • Table 128: Colorectal Cancer - Pipeline by EpiThany Inc
  • Table 129: Colorectal Cancer - Pipeline by Etubics Corp
  • Table 130: Colorectal Cancer - Pipeline by Exelixis Inc
  • Table 131: Colorectal Cancer - Pipeline by Exicure Inc
  • Table 132: Colorectal Cancer - Pipeline by F-star Biotechnology Ltd
  • Table 133: Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd
  • Table 134: Colorectal Cancer - Pipeline by Formosa Laboratories Inc
  • Table 135: Colorectal Cancer - Pipeline by Forty Seven Inc
  • Table 136: Colorectal Cancer - Pipeline by Fusion Antibodies Ltd
  • Table 137: Colorectal Cancer - Pipeline by Gene Techno Science Co Ltd
  • Table 138: Colorectal Cancer - Pipeline by Genentech Inc
  • Table 139: Colorectal Cancer - Pipeline by Genor BioPharma Co Ltd
  • Table 140: Colorectal Cancer - Pipeline by Genoscience Pharma
  • Table 141: Colorectal Cancer - Pipeline by Genzyme Corp
  • Table 142: Colorectal Cancer - Pipeline by Gilead Sciences Inc
  • Table 143: Colorectal Cancer - Pipeline by GlaxoSmithKline Plc
  • Table 144: Colorectal Cancer - Pipeline by Glenmark Pharmaceuticals Ltd
  • Table 145: Colorectal Cancer - Pipeline by Glycostem Therapeutics BV
  • Table 146: Colorectal Cancer - Pipeline by Glycotope GmbH
  • Table 147: Colorectal Cancer - Pipeline by Green Cross Corp
  • Table 148: Colorectal Cancer - Pipeline by Handok Inc
  • Table 149: Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals Co Ltd
  • Table 150: Colorectal Cancer - Pipeline by Heat Biologics Inc
  • Table 151: Colorectal Cancer - Pipeline by Hemispherx Biopharma Inc
  • Table 152: Colorectal Cancer - Pipeline by Humanigen Inc
  • Table 153: Colorectal Cancer - Pipeline by Humorigin Biotechnology Corp
  • Table 154: Colorectal Cancer - Pipeline by Hutchison MediPharma Ltd
  • Table 155: Colorectal Cancer - Pipeline by iDD biotech SAS
  • Table 156: Colorectal Cancer - Pipeline by Ideaya Biosciences Inc
  • Table 157: Colorectal Cancer - Pipeline by Ignyta Inc
  • Table 158: Colorectal Cancer - Pipeline by Ildong Pharmaceutical Co Ltd
  • Table 159: Colorectal Cancer - Pipeline by Immodulon Therapeutics Ltd
  • Table 160: Colorectal Cancer - Pipeline by ImmuneXcite Inc
  • Table 161: Colorectal Cancer - Pipeline by Immunomedics Inc
  • Table 162: Colorectal Cancer - Pipeline by Immunovative Therapies Ltd
  • Table 163: Colorectal Cancer - Pipeline by Incanthera Ltd
  • Table 164: Colorectal Cancer - Pipeline by Incyte Corp
  • Table 165: Colorectal Cancer - Pipeline by Innovation Pharmaceuticals Inc
  • Table 166: Colorectal Cancer - Pipeline by Innovent Biologics Inc
  • Table 167: Colorectal Cancer - Pipeline by Inovio Pharmaceuticals Inc
  • Table 168: Colorectal Cancer - Pipeline by Interprotein Corp
  • Table 169: Colorectal Cancer - Pipeline by Intezyne Technologies Inc
  • Table 170: Colorectal Cancer - Pipeline by Ionis Pharmaceuticals Inc
  • Table 171: Colorectal Cancer - Pipeline by Isofol Medical AB
  • Table 172: Colorectal Cancer - Pipeline by Jeil Pharmaceutical Co Ltd
  • Table 173: Colorectal Cancer - Pipeline by JHL Biotech Inc
  • Table 174: Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd
  • Table 175: Colorectal Cancer - Pipeline by Johnson & Johnson
  • Table 176: Colorectal Cancer - Pipeline by Kancera AB
  • Table 177: Colorectal Cancer - Pipeline by Karyopharm Therapeutics Inc
  • Table 178: Colorectal Cancer - Pipeline by Kura Oncology Inc
  • Table 179: Colorectal Cancer - Pipeline by Laboratorio ELEA SACIF y A
  • Table 180: Colorectal Cancer - Pipeline by LipoMedix Pharmaceutical Inc
  • Table 181: Colorectal Cancer - Pipeline by Loxo Oncology Inc
  • Table 182: Colorectal Cancer - Pipeline by Luye Pharma Group Ltd
  • Table 183: Colorectal Cancer - Pipeline by Mabion SA
  • Table 184: Colorectal Cancer - Pipeline by MacroGenics Inc
  • Table 185: Colorectal Cancer - Pipeline by Mantis Therapeutics BV
  • Table 186: Colorectal Cancer - Pipeline by Marina Biotech Inc
  • Table 187: Colorectal Cancer - Pipeline by Medesis Pharma SA
  • Table 188: Colorectal Cancer - Pipeline by MediaPharma SRL
  • Table 189: Colorectal Cancer - Pipeline by MedImmune LLC
  • Table 190: Colorectal Cancer - Pipeline by Medinet Co Ltd
  • Table 191: Colorectal Cancer - Pipeline by Medivir AB
  • Table 192: Colorectal Cancer - Pipeline by Merck & Co Inc
  • Table 193: Colorectal Cancer - Pipeline by Merck KGaA
  • Table 194: Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals Inc
  • Table 195: Colorectal Cancer - Pipeline by Merus NV
  • Table 196: Colorectal Cancer - Pipeline by Microlin Bio Inc
  • Table 197: Colorectal Cancer - Pipeline by Millennium Pharmaceuticals Inc
  • Table 198: Colorectal Cancer - Pipeline by Molecular Partners AG
  • Table 199: Colorectal Cancer - Pipeline by MolMed SpA
  • Table 200: Colorectal Cancer - Pipeline by Mologen AG
  • Table 201: Colorectal Cancer - Pipeline by Morphotek Inc
  • Table 202: Colorectal Cancer - Pipeline by Multimmune GmbH
  • Table 203: Colorectal Cancer - Pipeline by Mycenax Biotech Inc
  • Table 204: Colorectal Cancer - Pipeline by NantKwest Inc
  • Table 205: Colorectal Cancer - Pipeline by Natco Pharma Ltd
  • Table 206: Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corp
  • Table 207: Colorectal Cancer - Pipeline by Nektar Therapeutics
  • Table 208: Colorectal Cancer - Pipeline by Neovacs SA
  • Table 209: Colorectal Cancer - Pipeline by Nerviano Medical Sciences Srl
  • Table 210: Colorectal Cancer - Pipeline by Nippon Kayaku Co Ltd
  • Table 211: Colorectal Cancer - Pipeline by NormOxys Inc
  • Table 212: Colorectal Cancer - Pipeline by Northwest Biotherapeutics Inc
  • Table 213: Colorectal Cancer - Pipeline by Novartis AG
  • Table 214: Colorectal Cancer - Pipeline by Novogen Ltd
  • Table 215: Colorectal Cancer - Pipeline by Noxxon Pharma AG
  • Table 216: Colorectal Cancer - Pipeline by NuCana BioMed Ltd
  • Table 217: Colorectal Cancer - Pipeline by OBI Pharma Inc
  • Table 218: Colorectal Cancer - Pipeline by Omnitura Therapeutics Inc
  • Table 219: Colorectal Cancer - Pipeline by Oncobiologics Inc
  • Table 220: Colorectal Cancer - Pipeline by Oncology Research International Ltd
  • Table 221: Colorectal Cancer - Pipeline by Oncolytics Biotech Inc
  • Table 222: Colorectal Cancer - Pipeline by OncoMed Pharmaceuticals Inc
  • Table 223: Colorectal Cancer - Pipeline by Onconova Therapeutics Inc
  • Table 224: Colorectal Cancer - Pipeline by Ono Pharmaceutical Co Ltd
  • Table 225: Colorectal Cancer - Pipeline by Oryx GmbH & Co KG
  • Table 226: Colorectal Cancer - Pipeline by Otsuka Holdings Co Ltd
  • Table 227: Colorectal Cancer - Pipeline by Oxford BioMedica Plc
  • Table 228: Colorectal Cancer - Pipeline by Pfizer Inc
  • Table 229: Colorectal Cancer - Pipeline by Pharma Mar SA
  • Table 230: Colorectal Cancer - Pipeline by PharmAbcine Inc
  • Table 231: Colorectal Cancer - Pipeline by Pivotal BioSciences Inc
  • Table 232: Colorectal Cancer - Pipeline by PlantForm Corp
  • Table 233: Colorectal Cancer - Pipeline by Plexxikon Inc
  • Table 234: Colorectal Cancer - Pipeline by PLx Pharma Inc
  • Table 235: Colorectal Cancer - Pipeline by Precision Biologics Inc
  • Table 236: Colorectal Cancer - Pipeline by Propanac Biopharma Inc
  • Table 237: Colorectal Cancer - Pipeline by Provectus Biopharmaceuticals Inc
  • Table 238: Colorectal Cancer - Pipeline by PsiOxus Therapeutics Ltd
  • Table 239: Colorectal Cancer - Pipeline by Puma Biotechnology Inc
  • Table 240: Colorectal Cancer - Pipeline by Puretech Health plc
  • Table 241: Colorectal Cancer - Pipeline by R Pharm
  • Table 242: Colorectal Cancer - Pipeline by Rafael Pharmaceuticals Inc
  • Table 243: Colorectal Cancer - Pipeline by RedHill Biopharma Ltd
  • Table 244: Colorectal Cancer - Pipeline by Redx Pharma Plc
  • Table 245: Colorectal Cancer - Pipeline by Rexahn Pharmaceuticals Inc
  • Table 246: Colorectal Cancer - Pipeline by Rgenix Inc
  • Table 247: Colorectal Cancer - Pipeline by Rhizen Pharmaceuticals SA
  • Table 248: Colorectal Cancer - Pipeline by Richter Gedeon Nyrt
  • Table 249: Colorectal Cancer - Pipeline by Samumed LLC
  • Table 250: Colorectal Cancer - Pipeline by Sanofi
  • Table 251: Colorectal Cancer - Pipeline by Selvita SA
  • Table 252: Colorectal Cancer - Pipeline by Siamab Therapeutics Inc
  • Table 253: Colorectal Cancer - Pipeline by Sichuan Kelun Pharmaceutical Co Ltd
  • Table 254: Colorectal Cancer - Pipeline by Sigma-Tau SpA
  • Table 255: Colorectal Cancer - Pipeline by Sigmoid Pharma Ltd
  • Table 256: Colorectal Cancer - Pipeline by Sillajen Biotherapeutics
  • Table 257: Colorectal Cancer - Pipeline by Simcere Pharmaceutical Group
  • Table 258: Colorectal Cancer - Pipeline by Sorrento Therapeutics Inc
  • Table 259: Colorectal Cancer - Pipeline by Steba Biotech SA
  • Table 260: Colorectal Cancer - Pipeline by Sumitomo Dainippon Pharma Co Ltd
  • Table 261: Colorectal Cancer - Pipeline by SuviCa Inc
  • Table 262: Colorectal Cancer - Pipeline by Symphogen A/S
  • Table 263: Colorectal Cancer - Pipeline by SynDevRx Inc
  • Table 264: Colorectal Cancer - Pipeline by Synermore Biologics Co Ltd
  • Table 265: Colorectal Cancer - Pipeline by Taiho Pharmaceutical Co Ltd
  • Table 266: Colorectal Cancer - Pipeline by TaiwanJ Pharmaceuticals Co Ltd
  • Table 267: Colorectal Cancer - Pipeline by Takeda Pharmaceutical Co Ltd
  • Table 268: Colorectal Cancer - Pipeline by Targovax ASA
  • Table 269: Colorectal Cancer - Pipeline by Tarrex Biopharma Ltd
  • Table 270: Colorectal Cancer - Pipeline by Tarveda Therapeutics Inc
  • Table 271: Colorectal Cancer - Pipeline by tella Inc
  • Table 272: Colorectal Cancer - Pipeline by Tiltan Pharma Ltd
  • Table 273: Colorectal Cancer - Pipeline by Tocagen Inc
  • Table 274: Colorectal Cancer - Pipeline by TRACON Pharmaceuticals Inc
  • Table 275: Colorectal Cancer - Pipeline by Transgene SA
  • Table 276: Colorectal Cancer - Pipeline by United BioPharma Inc
  • Table 277: Colorectal Cancer - Pipeline by Vaccinex Inc
  • Table 278: Colorectal Cancer - Pipeline by VasGene Therapeutics Inc
  • Table 279: Colorectal Cancer - Pipeline by Vaximm AG
  • Table 280: Colorectal Cancer - Pipeline by ViiV Healthcare Ltd
  • Table 281: Colorectal Cancer - Pipeline by Vitality Biopharma Inc
  • Table 282: Colorectal Cancer - Pipeline by Wellstat Biologics Corp
  • Table 283: Colorectal Cancer - Pipeline by Wilex AG
  • Table 284: Colorectal Cancer - Pipeline by WntResearch AB
  • Table 285: Colorectal Cancer - Pipeline by Wuhan YZY Biopharma Co Ltd
  • Table 286: Colorectal Cancer - Pipeline by XBiotech Inc
  • Table 287: Colorectal Cancer - Pipeline by XuanZhu Pharma Co Ltd
  • Table 288: Colorectal Cancer - Pipeline by Yabao Pharmaceutical Group Co Ltd
  • Table 289: Colorectal Cancer - Pipeline by Zymeworks Inc
  • Table 290: Anal Cancer - Dormant Projects
  • Table 291: Rectal Cancer - Dormant Projects
  • Table 292: Colorectal Cancer - Dormant Projects
  • Table 293: Anal Cancer - Discontinued Products
  • Table 294: Colorectal Cancer - Discontinued Products

List of Figures

  • Figure 1: Number of Products under Development for Anal Cancer
  • Figure 2: Number of Products under Development by Companies Anal Cancer
  • Figure 3: Number of Products under Development for Rectal Cancer
  • Figure 4: Number of Products under Development by Companies Rectal Cancer
  • Figure 5: Number of Products under Development for Colorectal Cancer
  • Figure 6: Number of Products under Development by Companies Colorectal Cancer
  • Figure 7: Number of Products under Development by Universities/Institutes Colorectal Cancer
  • Figure 8: Number of Products by Top 10 Targets Anal Cancer
  • Figure 9: Number of Products by Stage and Top 10 Targets Anal Cancer
  • Figure 10: Number of Products by Top 10 Mechanism of Actions Anal Cancer
  • Figure 11: Number of Products by Stage and Top 10 Mechanism of Actions Anal Cancer
  • Figure 12: Number of Products by Routes of Administration Anal Cancer
  • Figure 13: Number of Products by Stage and Routes of Administration Anal Cancer
  • Figure 14: Number of Products by Molecule Types Anal Cancer
  • Figure 15: Number of Products by Stage and Molecule Types Anal Cancer
  • Figure 16: Number of Products by Top 10 Targets Rectal Cancer
  • Figure 17: Number of Products by Stage and Top 10 Targets Rectal Cancer
  • Figure 18: Number of Products by Top 10 Mechanism of Actions Rectal Cancer
  • Figure 19: Number of Products by Stage and Top 10 Mechanism of Actions Rectal Cancer
  • Figure 20: Number of Products by Routes of Administration Rectal Cancer
  • Figure 21: Number of Products by Stage and Routes of Administration Rectal Cancer
  • Figure 22: Number of Products by Molecule Types Rectal Cancer
  • Figure 23: Number of Products by Stage and Molecule Types Rectal Cancer
  • Figure 24: Number of Products by Top 10 Targets Colorectal Cancer
  • Figure 25: Number of Products by Stage and Top 10 Targets Colorectal Cancer
  • Figure 26: Number of Products by Top 10 Mechanism of Actions Colorectal Cancer
  • Figure 27: Number of Products by Stage and Top 10 Mechanism of Actions Colorectal Cancer
  • Figure 28: Number of Products by Routes of Administration Colorectal Cancer
  • Figure 29: Number of Products by Stage and Routes of Administration Colorectal Cancer
  • Figure 30: Number of Products by Top 10 Molecule Types Colorectal Cancer
  • Figure 31: Number of Products by Stage and Top 10 Molecule Types Colorectal Cancer
Back to Top